Daniel Theodorescu - Publications

Affiliations: 
University of Virginia, Charlottesville, VA 
Area:
Molecular Biology, Oncology

106 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Nickerson ML, Witte N, Im KM, Turan S, Owens C, Misner K, Tsang SX, Cai Z, Wu S, Dean M, Costello JC, Theodorescu D. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response. Oncogene. PMID 27270441 DOI: 10.1038/onc.2016.172  0.32
2016 Duberow DP, Brait M, Hoque MO, Theodorescu D, Sidransky D, Dasgupta S, Mathies RA. High-performance detection of somatic D-loop mutation in urothelial cell carcinoma patients by polymorphism ratio sequencing. Journal of Molecular Medicine (Berlin, Germany). PMID 27030170 DOI: 10.1007/S00109-016-1407-2  0.32
2016 Frantzi M, Van Kessel KE, Zwarthoff EC, Marquez M, Rava M, Malats N, Merseburger AS, Katafigiotis I, Stravodimos K, Mullen W, Zoidakis J, Makridakis M, Pejchinovski M, Critselis E, Lichtinghagen R, ... ... Theodorescu D, et al. Development and validation of urine-based peptide biomarker panels for detecting bladder cancer in a multi-center study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27026199 DOI: 10.1158/1078-0432.CCR-15-2715  0.32
2016 Jones RT, Felsenstein KM, Theodorescu D. Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer. The Urologic Clinics of North America. 43: 77-86. PMID 26614030 DOI: 10.1016/j.ucl.2015.08.007  0.32
2015 Gustafson DL, Fowles JS, Brown KC, Theodorescu D. Drug Selection in the Genomic Age: Application of the Coexpression Extrapolation Principle for Drug Repositioning in Cancer Therapy. Assay and Drug Development Technologies. 13: 623-7. PMID 26690765 DOI: 10.1089/adt.2015.29012.dlgdrrr  0.32
2015 Stern JL, Theodorescu D, Vogelstein B, Papadopoulos N, Cech TR. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers. Genes & Development. 29: 2219-24. PMID 26515115 DOI: 10.1101/Gad.269498.115  0.32
2015 Guin S, Ru Y, Agarwal N, Lew CR, Owens C, Comi GP, Theodorescu D. Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26490312 DOI: 10.1158/1078-0432.CCR-15-1706  0.32
2015 Hensel J, Duex JE, Owens C, Dancik GM, Edwards MG, Frierson HF, Theodorescu D. Patient mutation directed shRNA screen uncovers novel bladder tumor growth suppressors. Molecular Cancer Research : McR. PMID 26078295 DOI: 10.1158/1541-7786.MCR-15-0130  0.32
2015 Earl J, Rico D, Carrillo-de-Santa-Pau E, Rodríguez-Santiago B, Méndez-Pertuz M, Auer H, Gómez G, Grossman HB, Pisano DG, Schulz WA, Pérez-Jurado LA, Carrato A, Theodorescu D, Chanock S, Valencia A, et al. The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies. Bmc Genomics. 16: 403. PMID 25997541 DOI: 10.1186/S12864-015-1450-3  0.32
2015 Borah S, Xi L, Zaug AJ, Powell NM, Dancik GM, Cohen SB, Costello JC, Theodorescu D, Cech TR. Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science (New York, N.Y.). 347: 1006-10. PMID 25722414 DOI: 10.1126/Science.1260200  0.32
2015 Venkatasubramanian S, Dhiman R, Paidipally P, Cheekatla SS, Tripathi D, Welch E, Tvinnereim AR, Jones B, Theodorescu D, Barnes PF, Vankayalapati R. A rho GDP dissociation inhibitor produced by apoptotic T-cells inhibits growth of Mycobacterium tuberculosis. Plos Pathogens. 11: e1004617. PMID 25659138 DOI: 10.1371/journal.ppat.1004617  0.32
2015 Griner EM, Dancik GM, Costello JC, Owens C, Guin S, Edwards MG, Brautigan DL, Theodorescu D. RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer. Molecular Cancer Research : McR. 13: 483-92. PMID 25516960 DOI: 10.1158/1541-7786.MCR-14-0420  0.32
2015 Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, Knowles M, Theodorescu D, Czerniak BA, Efstathiou JA, Albert ML, Sridhar SS, Margulis V, Matin SF, Galsky MD, et al. Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward. Urologic Oncology. 33: 53-64. PMID 25065704 DOI: 10.1016/J.Urolonc.2014.06.013  0.32
2015 Lew CR, Guin S, Theodorescu D. Targeting glycogen metabolism in bladder cancer Nature Reviews Urology. 12: 383-391. DOI: 10.1038/nrurol.2015.111  0.32
2014 Dinney CP, Hansel D, McConkey D, Shipley W, Hagan M, Dreicer R, Lerner S, Czerniak B, Waldman F, Groshen S, True LD, Petricoin E, Theodorescu D, Hruszkewycz A, Bajorin D. Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum. Urologic Oncology. 32: 1108-15. PMID 25443274 DOI: 10.1016/J.Urolonc.2013.10.021  0.32
2014 Ostenfeld MS, Jeppesen DK, Laurberg JR, Boysen AT, Bramsen JB, Primdal-Bengtson B, Hendrix A, Lamy P, Dagnaes-Hansen F, Rasmussen MH, Bui KH, Fristrup N, Christensen EI, Nordentoft I, Morth JP, ... ... Theodorescu D, et al. Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer Research. 74: 5758-71. PMID 25261234 DOI: 10.1158/0008-5472.CAN-13-3512  0.32
2014 Nickerson ML, Dancik GM, Im KM, Edwards MG, Turan S, Brown J, Ruiz-Rodriguez C, Owens C, Costello JC, Guo G, Tsang SX, Li Y, Zhou Q, Cai Z, Moore LE, ... ... Theodorescu D, et al. Concurrent alterations in TERT, KDM6A, and the BRCA pathway in bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4935-48. PMID 25225064 DOI: 10.1158/1078-0432.CCR-14-0330  0.32
2014 Yan C, Liu D, Li L, Wempe MF, Guin S, Khanna M, Meier J, Hoffman B, Owens C, Wysoczynski CL, Nitz MD, Knabe WE, Ahmed M, Brautigan DL, Paschal BM, ... ... Theodorescu D, et al. Discovery and characterization of small molecules that target the GTPase Ral. Nature. 515: 443-7. PMID 25219851 DOI: 10.1038/Nature13713  0.32
2014 Costello JC, Theodorescu D. Decade in review-bladder cancer: international progress: from cytology to genomics. Nature Reviews. Urology. 11: 609-10. PMID 25179501 DOI: 10.1038/nrurol.2014.236  0.32
2014 Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R, Mahaffey S, Rossi S, Calin GA, Bemis L, Theodorescu D. The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Research. 42: e133. PMID 25063298 DOI: 10.1093/nar/gku631  0.32
2014 Guin S, Pollard C, Ru Y, Ritterson Lew C, Duex JE, Dancik G, Owens C, Spencer A, Knight S, Holemon H, Gupta S, Hansel D, Hellerstein M, Lorkiewicz P, Lane AN, ... ... Theodorescu D, et al. Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease. Journal of the National Cancer Institute. 106. PMID 24700805 DOI: 10.1093/Jnci/Dju062  0.32
2014 Kaur S, Momi N, Chakraborty S, Wagner DG, Horn AJ, Lele SM, Theodorescu D, Batra SK. Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis. Plos One. 9: e92742. PMID 24671186 DOI: 10.1371/Journal.Pone.0092742  0.32
2014 Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, ... ... Theodorescu D, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Science Translational Medicine. 6: 224ra24. PMID 24553385 DOI: 10.1126/Scitranslmed.3007094  0.32
2014 Dancik GM, Theodorescu D. Robust prognostic gene expression signatures in bladder cancer and lung adenocarcinoma depend on cell cycle related genes. Plos One. 9: e85249. PMID 24465512 DOI: 10.1371/journal.pone.0085249  0.32
2014 Frantzi M, Metzger J, Banks RE, Husi H, Klein J, Dakna M, Mullen W, Cartledge JJ, Schanstra JP, Brand K, Kuczyk MA, Mischak H, Vlahou A, Theodorescu D, Merseburger AS. Discovery and validation of urinary biomarkers for detection of renal cell carcinoma. Journal of Proteomics. 98: 44-58. PMID 24374379 DOI: 10.1016/j.jprot.2013.12.010  0.32
2014 Dancik GM, Theodorescu D. Pharmacogenomics in bladder cancer. Urologic Oncology. 32: 16-22. PMID 24360659 DOI: 10.1016/j.urolonc.2013.09.007  0.32
2014 Dancik GM, Owens CR, Iczkowski KA, Theodorescu D. A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors. Stem Cells (Dayton, Ohio). 32: 974-82. PMID 24357085 DOI: 10.1002/stem.1625  0.32
2014 Theodorescu D, Cech TR. Telomerase in bladder cancer: back to a better future? European Urology. 65: 370-1. PMID 24184027 DOI: 10.1016/J.Eururo.2013.10.019  0.32
2013 Guin S, Ru Y, Wynes MW, Mishra R, Lu X, Owens C, Barn AE, Vasu VT, Hirsch FR, Kern JA, Theodorescu D. Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 1492-501. PMID 24389431 DOI: 10.1097/Jto.0000000000000007  0.32
2013 Guo G, Sun X, Chen C, Wu S, Huang P, Li Z, Dean M, Huang Y, Jia W, Zhou Q, Tang A, Yang Z, Li X, Song P, Zhao X, ... ... Theodorescu D, et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nature Genetics. 45: 1459-63. PMID 24121792 DOI: 10.1038/ng.2798  0.32
2013 Solomon DA, Kim JS, Bondaruk J, Shariat SF, Wang ZF, Elkahloun AG, Ozawa T, Gerard J, Zhuang D, Zhang S, Navai N, Siefker-Radtke A, Phillips JJ, Robinson BD, Rubin MA, ... ... Theodorescu D, et al. Frequent truncating mutations of STAG2 in bladder cancer. Nature Genetics. 45: 1428-30. PMID 24121789 DOI: 10.1038/Ng.2800  0.32
2013 Wang H, Ru Y, Sanchez-Carbayo M, Wang X, Kieft JS, Theodorescu D. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2850-60. PMID 23575475 DOI: 10.1158/1078-0432.CCR-12-3084  0.32
2013 Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, ... ... Theodorescu D, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proceedings of the National Academy of Sciences of the United States of America. 110: 6021-6. PMID 23530248 DOI: 10.1093/Neuonc/Nou206.18  0.32
2013 Said N, Frierson HF, Sanchez-Carbayo M, Brekken RA, Theodorescu D. Loss of SPARC in bladder cancer enhances carcinogenesis and progression. The Journal of Clinical Investigation. 123: 751-66. PMID 23321672 DOI: 10.1172/JCI64782  0.32
2013 Sternberg CN, Bellmunt J, Sonpavde G, Siefker-Radtke AO, Stadler WM, Bajorin DF, Dreicer R, George DJ, Milowsky MI, Theodorescu D, Vaughn DJ, Galsky MD, Soloway MS, Quinn DI. ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings. European Urology. 63: 58-66. PMID 22917984 DOI: 10.1016/j.eururo.2012.08.010  0.32
2013 Griner EM, Churchill ME, Brautigan DL, Theodorescu D. PKCα phosphorylation of RhoGDI2 at Ser31 disrupts interactions with Rac1 and decreases GDI activity. Oncogene. 32: 1010-7. PMID 22469974 DOI: 10.1038/onc.2012.124  0.32
2013 Said N, Frierson HF, Sanchez-Carbayo M, Brekken RA, Theodorescu D. Loss of SPARC in bladder cancer enhances carcinogenesis and progression (Journal of Clinical Investigation (2013) 123, 2 (751-766) DOI: 10.1172/JCI64782) Journal of Clinical Investigation. 123: 4089. DOI: 10.1172/JCI71241  0.32
2012 DeGraff DJ, Clark PE, Cates JM, Yamashita H, Robinson VL, Yu X, Smolkin ME, Chang SS, Cookson MS, Herrick MK, Shariat SF, Steinberg GD, Frierson HF, Wu XR, Theodorescu D, et al. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation. Plos One. 7: e36669. PMID 22590586 DOI: 10.1371/journal.pone.0036669  0.32
2012 Smith SC, Baras AS, Owens CR, Dancik G, Theodorescu D. Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer. Cancer Research. 72: 3480-91. PMID 22586063 DOI: 10.1158/0008-5472.CAN-11-3966  0.56
2012 Said N, Sanchez-Carbayo M, Smith SC, Theodorescu D. RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration. The Journal of Clinical Investigation. 122: 1503-18. PMID 22406535 DOI: 10.1172/JCI61392  0.56
2011 Dancik GM, Ru Y, Owens CR, Theodorescu D. A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers. Cancer Research. 71: 7398-409. PMID 22012889 DOI: 10.1158/0008-5472.CAN-11-2427  0.32
2011 Gui Y, Guo G, Huang Y, Hu X, Tang A, Gao S, Wu R, Chen C, Li X, Zhou L, He M, Li Z, Sun X, Jia W, Chen J, ... ... Theodorescu D, et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nature Genetics. 43: 875-8. PMID 21822268 DOI: 10.1038/ng.907  0.32
2011 Ru Y, Dancik GM, Theodorescu D. Biomarkers for prognosis and treatment selection in advanced bladder cancer patients. Current Opinion in Urology. 21: 420-7. PMID 21814055 DOI: 10.1097/MOU.0b013e32834956d6  0.32
2011 Nitz MD, Harding MA, Smith SC, Thomas S, Theodorescu D. RREB1 transcription factor splice variants in urologic cancer. The American Journal of Pathology. 179: 477-86. PMID 21703425 DOI: 10.1016/j.ajpath.2011.03.038  0.32
2011 Jerde TJ, Wu Z, Theodorescu D, Bushman W. Regulation of phosphatase homologue of tensin protein expression by bone morphogenetic proteins in prostate epithelial cells. The Prostate. 71: 791-800. PMID 21456062 DOI: 10.1002/pros.21295  0.32
2011 Smith SC, Havaleshko DM, Moon K, Baras AS, Lee J, Bekiranov S, Burke DJ, Theodorescu D. Use of yeast chemigenomics and COXEN informatics in preclinical evaluation of anticancer agents. Neoplasia (New York, N.Y.). 13: 72-80. PMID 21253455 DOI: 10.1593/neo.101214  0.56
2010 Wang H, Owens C, Chandra N, Conaway MR, Brautigan DL, Theodorescu D. Phosphorylation of RalB is important for bladder cancer cell growth and metastasis. Cancer Research. 70: 8760-9. PMID 20940393 DOI: 10.1158/0008-5472.CAN-10-0952  0.32
2010 Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D'Haese P, Dominiczak AF, Dakna M, Dihazi H, ... ... Theodorescu D, et al. Recommendations for biomarker identification and qualification in clinical proteomics. Science Translational Medicine. 2: 46ps42. PMID 20739680 DOI: 10.1126/Scitranslmed.3001249  0.32
2010 Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, ... ... Theodorescu D, et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Molecular & Cellular Proteomics : McP. 9: 2424-37. PMID 20616184 DOI: 10.1074/Mcp.M110.001917  0.32
2010 Hansel DE, Platt E, Orloff M, Harwalker J, Sethu S, Hicks JL, De Marzo A, Steinle RE, Hsi ED, Theodorescu D, Ching CB, Eng C. Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma. The American Journal of Pathology. 176: 3062-72. PMID 20395440 DOI: 10.2353/Ajpath.2010.090872  0.32
2010 Pollard C, Smith SC, Theodorescu D. Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC). Expert Reviews in Molecular Medicine. 12: e10. PMID 20334706 DOI: 10.1017/S1462399410001407  0.56
2010 Cathro HP, Smolkin ME, Theodorescu D, Jo VY, Ferrone S, Frierson HF. Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas. Cancer Immunology, Immunotherapy : Cii. 59: 465-72. PMID 19756593 DOI: 10.1007/S00262-009-0765-9  0.32
2009 Dong L, Bard AJ, Richards WG, Nitz MD, Theodorescu D, Bueno R, Gordon GJ. A gene expression ratio-based diagnostic test for bladder cancer. Advances and Applications in Bioinformatics and Chemistry : Aabc. 2: 17-22. PMID 21918612 DOI: 10.2147/AABC.S4148  0.32
2009 Ehdaie B, Smith SC, Theodorescu D. Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 3: S232-6. PMID 20019992  0.56
2009 Hussain MH, Wood DP, Bajorin DF, Bochner BH, Dreicer R, Lamm DL, O'Donnell MA, Siefker-Radtke AO, Theodorescu D, Dinney CP. Bladder cancer: narrowing the gap between evidence and practice. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5680-4. PMID 19858384 DOI: 10.1200/JCO.2009.23.6901  0.32
2009 Pollard C, Nitz M, Baras A, Williams P, Moskaluk C, Theodorescu D. Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy. The American Journal of Pathology. 175: 1824-30. PMID 19815704 DOI: 10.2353/ajpath.2009.090155  0.32
2009 Slack-Davis JK, Hershey ED, Theodorescu D, Frierson HF, Parsons JT. Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model Molecular Cancer Therapeutics. 8: 2470-2477. PMID 19671741 DOI: 10.1158/1535-7163.Mct-09-0262  0.32
2009 Schiffer E, Vlahou A, Petrolekas A, Stravodimos K, Tauber R, Geschwend JE, Neuhaus J, Stolzenburg JU, Conaway MR, Mischak H, Theodorescu D. Prediction of muscle-invasive bladder cancer using urinary proteomics. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4935-43. PMID 19602546 DOI: 10.1158/1078-0432.CCR-09-0226  0.32
2009 Said N, Frierson HF, Chernauskas D, Conaway M, Motamed K, Theodorescu D. The role of SPARC in the TRAMP model of prostate carcinogenesis and progression. Oncogene. 28: 3487-98. PMID 19597474 DOI: 10.1038/onc.2009.205  0.32
2009 Haubitz M, Good DM, Woywodt A, Haller H, Rupprecht H, Theodorescu D, Dakna M, Coon JJ, Mischak H. Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis. Molecular & Cellular Proteomics : McP. 8: 2296-307. PMID 19564150 DOI: 10.1074/Mcp.M800529-Mcp200  0.32
2009 Wu Y, Moissoglu K, Wang H, Wang X, Frierson HF, Schwartz MA, Theodorescu D. Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function. Proceedings of the National Academy of Sciences of the United States of America. 106: 5807-12. PMID 19321744 DOI: 10.1073/Pnas.0810094106  0.32
2009 Moissoglu K, McRoberts KS, Meier JA, Theodorescu D, Schwartz MA. Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases. Cancer Research. 69: 2838-44. PMID 19276387 DOI: 10.1158/0008-5472.Can-08-1397  0.32
2009 Smith SC, Theodorescu D. Learning therapeutic lessons from metastasis suppressor proteins. Nature Reviews. Cancer. 9: 253-64. PMID 19242414 DOI: 10.1038/nrc2594  0.56
2009 Smith SC, Nicholson B, Nitz M, Frierson HF, Smolkin M, Hampton G, El-Rifai W, Theodorescu D. Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination. The American Journal of Pathology. 174: 371-9. PMID 19147813 DOI: 10.2353/ajpath.2009.080538  0.32
2008 Coon JJ, Zürbig P, Dakna M, Dominiczak AF, Decramer S, Fliser D, Frommberger M, Golovko I, Good DM, Herget-Rosenthal S, Jankowski J, Julian BA, Kellmann M, Kolch W, Massy Z, ... ... Theodorescu D, et al. CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics. Clinical Applications. 2: 964. PMID 20130789 DOI: 10.1002/Prca.200800024  0.32
2008 Schwartz MA, McRoberts K, Coyner M, Andarawewa KL, Frierson HF, Sanders JM, Swenson S, Markland F, Conaway MR, Theodorescu D. Integrin agonists as adjuvants in chemotherapy for melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 6193-7. PMID 18829498 DOI: 10.1158/1078-0432.Ccr-08-1285  0.32
2008 Jones RA, Taylor AG, Bourguignon C, Steeves R, Fraser G, Lippert M, Theodorescu D, Mathews H, Kilbridge KL. Family interactions among African American prostate cancer survivors. Family & Community Health. 31: 213-20. PMID 18552602 DOI: 10.1097/01.Fch.0000324478.55706.Fe  0.32
2008 Nitz MD, Harding MA, Theodorescu D. Invasion and metastasis models for studying RhoGDI2 in bladder cancer. Methods in Enzymology. 439: 219-33. PMID 18374168 DOI: 10.1016/S0076-6879(07)00417-X  0.32
2007 Mischak H, Apweiler R, Banks RE, Conaway M, Coon J, Dominiczak A, Ehrich JH, Fliser D, Girolami M, Hermjakob H, Hochstrasser D, Jankowski J, Julian BA, Kolch W, Massy ZA, ... ... Theodorescu D, et al. Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics. Clinical Applications. 1: 148-56. PMID 21136664 DOI: 10.1002/Prca.200600771  0.32
2007 Bigler D, Gioeli D, Conaway MR, Weber MJ, Theodorescu D. Rap2 regulates androgen sensitivity in human prostate cancer cells. The Prostate. 67: 1590-9. PMID 17918750 DOI: 10.1002/pros.20644  0.32
2007 Smith SC, Oxford G, Baras AS, Owens C, Havaleshko D, Brautigan DL, Safo MK, Theodorescu D. Expression of ral GTPases, their effectors, and activators in human bladder cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3803-13. PMID 17606711 DOI: 10.1158/1078-0432.CCR-06-2419  0.32
2007 Jones RA, Taylor AG, Bourguignon C, Steeves R, Fraser G, Lippert M, Theodorescu D, Mathews H, Kilbridge KL. Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors. Oncology Nursing Forum. 34: 359-64. PMID 17573300 DOI: 10.1188/07.Onf.359-364  0.32
2007 Herlevsen M, Oxford G, Ptak C, Shabanowitz J, Hunt DF, Conaway M, Theodorescu D. A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer. Biochemical and Biophysical Research Communications. 352: 549-55. PMID 17126809 DOI: 10.1016/J.Bbrc.2006.11.067  0.32
2007 Wu Y, McRoberts K, Berr SS, Frierson HF, Conaway M, Theodorescu D. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia Oncogene. 26: 765-773. PMID 16878152 DOI: 10.1038/sj.onc.1209835  0.32
2006 Keim JL, Theodorescu D. Robot-assisted radical cystectomy in the management of bladder cancer Thescientificworldjournal. 6: 2560-2565. PMID 17619731 DOI: 10.1100/tsw.2006.396  0.32
2006 Moon K, Stukenborg GJ, Keim J, Theodorescu D. Cancer incidence after localized therapy for prostate cancer Cancer. 107: 991-998. PMID 16878323 DOI: 10.1002/cncr.22083  0.32
2006 Zürbig P, Renfrow MB, Schiffer E, Novak J, Walden M, Wittke S, Just I, Pelzing M, Neusüss C, Theodorescu D, Root KE, Ross MM, Mischak H. Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis. 27: 2111-25. PMID 16645980 DOI: 10.1002/elps.200500827  0.32
2006 Miller NL, Theodorescu D. Status of robotic cystectomy in 2005. World Journal of Urology. 24: 180-7. PMID 16557389 DOI: 10.1007/s00345-006-0066-2  0.32
2006 Theodorescu D, Wittke S, Ross MM, Walden M, Conaway M, Just I, Mischak H, Frierson HF. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. The Lancet. Oncology. 7: 230-40. PMID 16510332 DOI: 10.1016/S1470-2045(06)70584-8  0.32
2006 Smith SC, Oxford G, Wu Z, Nitz MD, Conaway M, Frierson HF, Hampton G, Theodorescu D. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Research. 66: 1917-22. PMID 16488989 DOI: 10.1158/0008-5472.CAN-05-3855  0.32
2005 Titus B, Frierson HF, Conaway M, Ching K, Guise T, Chirgwin J, Hampton G, Theodorescu D. Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. Cancer Research. 65: 7320-7. PMID 16103083 DOI: 10.1158/0008-5472.CAN-05-1403  0.32
2005 Oxford G, Owens CR, Titus BJ, Foreman TL, Herlevsen MC, Smith SC, Theodorescu D. RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Research. 65: 7111-20. PMID 16103060 DOI: 10.1158/0008-5472.CAN-04-1957  0.56
2005 Titus B, Schwartz MA, Theodorescu D. Rho proteins in cell migration and metastasis. Critical Reviews in Eukaryotic Gene Expression. 15: 103-14. PMID 16022631 DOI: 10.1615/Critreveukaryotgeneexpr.V15.I2.20  0.32
2005 Globus T, Theodorescu D, Frierson H, Khromova T, Woolard D. Terahertz spectroscopic characterization of cancer cells Progress in Biomedical Optics and Imaging - Proceedings of Spie. 5692: 233-240. DOI: 10.1117/12.594391  0.32
2004 Nicholson BE, Frierson HF, Conaway MR, Seraj JM, Harding MA, Hampton GM, Theodorescu D. Profiling the evolution of human metastatic bladder cancer. Cancer Research. 64: 7813-21. PMID 15520187 DOI: 10.1158/0008-5472.CAN-04-0826  0.32
2004 Miller NL, Theodorescu D. Health-related quality of life after prostate brachytherapy. Bju International. 94: 487-91. PMID 15329098 DOI: 10.1111/j.1464-410X.2003.04989.x  0.32
2004 Gildea JJ, Herlevsen M, Harding MA, Gulding KM, Moskaluk CA, Frierson HF, Theodorescu D. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Oncogene. 23: 6788-97. PMID 15273733 DOI: 10.1038/sj.onc.1207599  0.32
2004 Theodorescu D, Frierson HF. When is a negative lymph node really negative? Molecular tools for the detection of lymph node metastasis from urological cancer. Urologic Oncology. 22: 256-9. PMID 15271328 DOI: 10.1016/j.urolonc.2004.05.001  0.32
2004 Theodorescu D, Sapinoso LM, Conaway MR, Oxford G, Hampton GM, Frierson HF. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer Clinical Cancer Research. 10: 3800-3806. PMID 15173088 DOI: 10.1158/1078-0432.CCR-03-0653  0.32
2004 Makhlouf AA, Krupski TL, Kunkle D, Theodorescu D. The effect of sampling more cores on the predictive accuracy of pathological grade and tumour distribution in the prostate biopsy Bju International. 93: 271-274. PMID 14764121 DOI: 10.1111/j.1464-410X.2004.04600.x  0.32
2003 Hall JD, Bissonette EA, Boyd JC, Theodorescu D. Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study. Bju International. 91: 603-7. PMID 12699468 DOI: 10.1046/j.1464-410X.2003.04181.x  0.32
2003 Bigler D, Gulding KM, Dann R, Sheabar FZ, Conaway MR, Theodorescu D. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action. Oncogene. 22: 1261-72. PMID 12606954 DOI: 10.1038/sj.onc.1206242  0.32
2003 Miller NL, Bissonette EA, Bahnson R, Wilson J, Theodorescu D. Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy. Cancer. 97: 1203-10. PMID 12599226 DOI: 10.1002/cncr.11177  0.32
2003 Hall JD, Boyd JC, Lippert MC, Theodorescu D. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey. Urology. 61: 402-7. PMID 12597956 DOI: 10.1016/S0090-4295(02)02162-3  0.32
2003 Myers CE, Theodorescu D. Antioxidants and Phytotherapy Prostate Cancer: Science and Clinical Practice. 517-528. DOI: 10.1016/B978-012286981-5/50057-4  0.32
2002 Smith EB, Frierson HF, Mills SE, Boyd JC, Theodorescu D. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading? Cancer. 94: 2282-7. PMID 12001128 DOI: 10.1002/cncr.10457  0.32
2001 Chen C, Frierson HF, Haggerty PF, Theodorescu D, Gregory CW, Dong JT. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas Genomics. 77: 135-144. PMID 11597138 DOI: 10.1006/geno.2001.6631  0.32
2001 Santen RJ, Petroni GR, Fisch MJ, Myers CE, Theodorescu D, Cohen RB. Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma Cancer. 92: 2095-2101. PMID 11596025 DOI: 10.1002/1097-0142(20011015)92:8<2095::AID-CNCR1550>3.0.CO;2-Y  0.32
2000 Gardner TA, Bissonette EA, Petroni GR, McClain R, Sokoloff MH, Theodorescu D. Surgical postoperative factors affecting length of hospital stay after radical prostatectomy Cancer. 89: 424-430. PMID 10918175 DOI: 10.1002/1097-0142(20000715)89:2<424::AID-CNCR30>3.0.CO;2-6  0.32
2000 Sheta EA, Harding MA, Conaway MR, Theodorescu D. Focal adhesion kinase, Rap1, and transcriptional induction of vascular endothelial growth factor Journal of the National Cancer Institute. 92: 1065-1073. PMID 10880549 DOI: 10.1093/JNCI/92.13.1065  0.32
2000 Im DS, Heise CE, Harding MA, George SR, O'Dowd BF, Theodorescu D, Lynch KR. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate. Molecular Pharmacology. 57: 753-9. PMID 10727522 DOI: 10.1124/Mol.57.4.753  0.32
1999 Theodorescu D, Frierson HF, Sikes RA. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy Journal of Urology. 161: 1442-1448. PMID 10210369 DOI: 10.1016/S0022-5347(05)68919-7  0.32
1997 Theodorescu D, Broder SR, Boyd JC, Mills SE, Frierson HF. Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer. 80: 2109-19. PMID 9392333 DOI: 10.1002/(SICI)1097-0142(19971201)80:11<2109::AID-CNCR10>3.0.CO;2-2  0.32
1997 Theodorescu D, Broder SR, Boyd JC, Mills SE, Frierson HF. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate. The Journal of Urology. 158: 131-7. PMID 9186339 DOI: 10.1097/00005392-199707000-00040  0.32
1996 Theodorescu D, Russo P, Zhang ZF, Morash C, Fair WR. Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. The Journal of Urology. 155: 1626-31. PMID 8627839 DOI: 10.1016/S0022-5347(01)66147-0  0.32
1992 Wu S, Theodorescu D, Kerbel RS, Willson JKV, Mulder KM, Humphrey LE, Brattain MG. TGF-βi is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector Journal of Cell Biology. 116: 187-196. PMID 1730743 DOI: 10.1083/jcb.116.1.187  0.32
Show low-probability matches.